abstract |
The present invention encompasses compounds of general formula (1) n n n n n n n n n n wherein B, R 1 to R 5 , R x , m and n are defined as in claim 1 , which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and their use in such treatment. |